Rallybio (RLYB) Research & Development (2023 - 2025)
Historic Research & Development for Rallybio (RLYB) over the last 3 years, with Q3 2025 value amounting to $4.1 million.
- Rallybio's Research & Development fell 4972.09% to $4.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $23.3 million, marking a year-over-year decrease of 5338.89%. This contributed to the annual value of $41.5 million for FY2024, which is 2248.06% down from last year.
- According to the latest figures from Q3 2025, Rallybio's Research & Development is $4.1 million, which was down 4972.09% from $6.1 million recorded in Q2 2025.
- Rallybio's Research & Development's 5-year high stood at $15.9 million during Q4 2023, with a 5-year trough of $4.1 million in Q3 2025.
- Over the past 3 years, Rallybio's median Research & Development value was $11.2 million (recorded in 2023), while the average stood at $10.1 million.
- Its Research & Development has fluctuated over the past 5 years, first soared by 1547.94% in 2024, then plummeted by 5574.37% in 2025.
- Quarter analysis of 3 years shows Rallybio's Research & Development stood at $15.9 million in 2023, then tumbled by 53.62% to $7.4 million in 2024, then plummeted by 43.9% to $4.1 million in 2025.
- Its Research & Development stands at $4.1 million for Q3 2025, versus $6.1 million for Q2 2025 and $5.7 million for Q1 2025.